Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_43201 | 71 | 1.49 | Mlig455_004169, Mlig455_004193 | Neo: - Age: Down-Up-Up |
Mlig455_004169 {REF} {Length: 1823} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=74.3, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243} Mlig455_004193 {REF} {Length: 1806} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.131 | 1.344 | 0.99974 | 1.00000 | |
RegionR2 | 1.868 | 1.344 | 0.19043 | 0.54602 | |
RegionR3 | -1.549 | 1.344 | 0.99979 | 1.00000 | |
RegionR4 | 0.114 | 1.344 | 0.99975 | 1.00000 | |
RegionR5 | -0.794 | 1.344 | 0.99987 | 1.00000 | |
RegionR6 | 0.428 | 1.344 | 0.34727 | 0.93280 | |
RegionR7 | 3.116 | 1.344 | 0.02279 | 0.28157 | |
RegionR8 | -1.052 | 1.344 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.675 | 1.344 | 0.99994 | 1.00000 | |
RegenerationR2 | -0.455 | 1.344 | 0.62123 | 0.92354 | |
RegenerationR3 | 2.602 | 1.344 | 0.15886 | 0.59097 | |
RegenerationR4 | 0.457 | 1.344 | 0.35846 | 0.78664 | |
RegenerationR5 | 1.35 | 1.344 | 0.25478 | 0.68780 | |
RegenerationR6 | 2.097 | 1.344 | 0.25416 | 0.60403 | |
RegenerationBL | 1.672 | 1.344 | 0.47916 | 0.84466 | |
RegenerationTP | 1.986 | 1.344 | 0.51617 | 0.91162 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_43201 | 71 | 1.49 | Mlig455_004169, Mlig455_004193 | Neo: - Age: Down-Up-Up |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_004169 {REF} {Length: 1823} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=74.3, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243} Mlig455_004193 {REF} {Length: 1806} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243} |
|
2. | MligTC455_11863 | 67 | 1.4 | Mlig455_037840 | Neo: - Age: - Region-enriched R7: 3.761/0.04261 |
GRM3 | 2.487 | - | - | 0.951 | - | 0.831 | 0.705 | Mlig455_037840 {REF} {Length: 3733} {Pfam: Receptor family ligand binding region [PF01094.30, score=244.3]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=189.6]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=36.4]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=701, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=626, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=818, Expect=0.0]} {RNA1310_32870} {RNA815_40865} |
3. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 1.871 | - | - | 0.962 | - | 0.909 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
4. | MligTC455_29138 | 150 | 3.13 | Mlig455_047030 | Neo: - Age: Up-Down-Up |
EFR3A | 1.857 | - | - | 0.968 | - | 0.889 | - | Mlig455_047030 {REF} {Length: 5267} {TRANSSPLICED} {Pfam: ZIP Zinc transporter [PF02535.24, score=66.2]} {Human: ENSG00000132294, EFR3A, EFR3 homolog A, [RH, Score=343, Expect=2e-103]; ENSG00000084710, EFR3B, EFR3 homolog B, [RH, Score=327, Expect=2e-97]} {Mouse: ENSMUSG00000015002, Efr3a, EFR3 homolog A, [Score=346, Expect=4e-104]} {Dmel: FBgn0086784, stmA, stambha A, [Score=315, Expect=4e-93]} {Celegans: WBGene00016311, C32D5.3, Protein EFR3 homolog, [Score=249, Expect=2e-69]} {Smed: dd_Smed_v6_3212_0_1, dd_Smed_v6_3212_0_1, [RH, Score=397, Expect=5e-123]} {RNA1509_14238} {RNA1310_2165.2} {RNA815_4536} |
5. | MligTC455_13778 | 74 | 1.55 | Mlig455_057444 | Neo: - Age: Up-Down-Down |
FGG | 1.856 | - | - | 0.975 | - | - | 0.881 | Mlig455_057444 {REF} {Length: 1868} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.2]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=96.3, Expect=4e-22]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.4, Expect=3e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=92.4, Expect=1e-20]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=92.0, Expect=2e-20]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=97.4, Expect=2e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=84.0, Expect=7e-18]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=2e-14]} {RNA1509_51521} {RNA1310_49947} {RNA815_34508} |
6. | MligTC455_13403 | 157 | 3.27 | Mlig455_058321 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.878/0.03174 |
LARP1 | 1.853 | - | - | 0.967 | - | 0.886 | - | Mlig455_058321 {REF} {Length: 2328} {Human: ENSG00000155506, LARP1, La ribonucleoprotein domain family member 1, [Score=178, Expect=6e-52]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=178, Expect=5e-52]; ENSMUSG00000025762, Larp1b, La ribonucleoprotein domain family, member 1B, [Score=171, Expect=9e-54]} {Dmel: FBgn0261618, larp, La related protein, [Score=172, Expect=4e-50]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=136, Expect=2e-37]} {Smed: dd_Smed_v6_2667_0_1, dd_Smed_v6_2667_0_1, [Score=170, Expect=2e-49]} {RNA1509_29509} {RNA1310_3597.2, RNA1509_29509} {RNA1509_29509, RNA815_2607} |
7. | MligTC455_53117 | 86 | 1.79 | Mlig455_029454 | Neo: - Age: logFC(26M/2M)=-0.687 |
CHRNA4 | 1.845 | - | - | - | - | 0.893 | 0.952 | Mlig455_029454 {REF} {Length: 3116} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=110.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.7]} {Human: ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=3e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=210, Expect=5e-60]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=211, Expect=1e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=209, Expect=5e-60]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=207, Expect=5e-60]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=5e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=204, Expect=2e-56]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=1e-57]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=451, Expect=1e-152]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
8. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
1.787 | - | - | - | - | 0.959 | 0.828 | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
9. | MligTC455_03359 | 17 | 0.35 | Mlig455_037386 | Neo: - Age: - |
1.784 | - | - | - | 0.813 | 0.971 | - | Mlig455_037386 {REF} {Length: 1323} {Pfam: Lectin C-type domain [PF00059.23, score=22.2]} {RNA1310_22051} {RNA815_28288} | |
10. | MligTC455_48229 | 140 | 2.92 | Mlig455_025844 | Neo: - Age: - |
1.778 | - | - | 0.976 | - | - | 0.802 | Mlig455_025844 {REF} {Length: 3215} {Pfam: Domain of unknown function (DUF4139) [PF13598.8, score=115.0]} {Celegans: WBGene00016877, C52D10.3, [Score=176, Expect=4e-49]} {Smed: dd_Smed_v6_3629_0_1, dd_Smed_v6_3629_0_1, [Score=280, Expect=3e-88]} {RNA1509_25634} {RNA1310_6356.2} {RNA815_15997} | |
11. | MligTC455_41250 | 104 | 2.16 | Mlig455_010456, Mlig455_010476, Mlig455_061901 | Neo: - Age: - |
1.753 | - | - | - | 0.970 | 0.783 | - | Mlig455_010456 {REF} {Length: 2561} {RNA1310_39237} {RNA815_40339} Mlig455_010476 {REF} {Length: 2776} {RNA1310_39237} {RNA815_40339} Mlig455_061901 {REF} {Length: 2797} {RNA1310_39237} {RNA815_40339} |
|
12. | MligTC455_42779 | 52 | 1.08 | Mlig455_034985 | Neo: - Age: - |
TIA1 | 1.746 | - | - | 0.966 | - | - | 0.780 | Mlig455_034985 {REF} {Length: 2883} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=137.6]; RNA binding motif [PF08777.13, score=27.7]; RNA recognition motif [PF16367.7, score=27.3]; Cytosolic domain of 10TM putative phosphate transporter [PF14703.8, score=22.0]; Nup53/35/40-type RNA recognition motif [PF05172.15, score=19.3]; Nup53/35/40-type RNA recognition motif [PF14605.8, score=19.0]} {Human: ENSG00000116001, TIA1, TIA1 cytotoxic granule associated RNA binding protein, [RH, Score=236, Expect=6e-74]; ENSG00000151923, TIAL1, TIA1 cytotoxic granule associated RNA binding protein like 1, [RH, Score=225, Expect=2e-69]} {Mouse: ENSMUSG00000071337, Tia1, cytotoxic granule-associated RNA binding protein 1, [RH, Score=234, Expect=2e-73]; ENSMUSG00000030846, Tial1, Tia1 cytotoxic granule-associated RNA binding protein-like 1, [RH, Score=225, Expect=2e-70]} {Dmel: FBgn0085391, trv, trivet, [RH, Score=242, Expect=4e-75]} {Celegans: WBGene00015943, tiar-1, TIA-1/TIAL RNA binding protein homolog, [RH, Score=229, Expect=2e-71]} {Smed: dd_Smed_v6_10924_0_1, dd_Smed_v6_10924_0_1, [RH, Score=359, Expect=2e-122]} {RNA1509_20262} {RNA1310_6771} {RNA815_11494} |
13. | MligTC455_45231 | 73 | 1.52 | Mlig455_027244 | Neo: - Age: Up-Down-Down |
SLC16A14 | 1.735 | - | - | 0.778 | - | 0.957 | - | Mlig455_027244 {REF} {Length: 2892} {Pfam: Major Facilitator Superfamily [PF07690.18, score=114.7]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=148, Expect=8e-38]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=3e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=312, Expect=1e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=301, Expect=7e-94]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=198, Expect=1e-55]} {RNA1310_24115} {RNA815_15685} |
14. | MligTC455_40574 | 185 | 3.86 | Mlig455_055994 | Neo: - Age: logFC(26M/2M)=0.739 |
1.723 | - | - | 0.951 | - | 0.772 | - | Mlig455_055994 {REF} {Length: 2305} {Pfam: Modifier of rudimentary (Mod(r)) protein [PF07200.15, score=20.1]} {RNA1509_55733} {RNA1310_23110} {RNA815_14988.1} | |
15. | MligTC455_19097 | 120 | 2.49 | Mlig455_035179 | Neo: - Age: - Region-enriched R2: 5.873/0.00339 |
KCNK3 | 1.718 | - | - | 0.768 | - | 0.950 | - | Mlig455_035179 {REF} {Length: 2899} {Pfam: Ion channel [PF07885.18, score=103.1]; Ion transport protein [PF00520.33, score=23.8]} {Human: ENSG00000171303, KCNK3, potassium two pore domain channel subfamily K member 3, [Score=67.0, Expect=5e-11]; ENSG00000169427, KCNK9, potassium two pore domain channel subfamily K member 9, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]} {Dmel: FBgn0033257, sand, sandman, [Score=105, Expect=4e-24]} {Celegans: WBGene00006690, twk-39, TWiK family of potassium channels, [RH, Score=117, Expect=4e-27]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=188, Expect=7e-51]} {RNA1310_31604} {RNA815_54785} |
16. | MligTC455_26832 | 211 | 4.39 | Mlig455_000690 | Neo: - Age: Down-Up-Down |
ANK3 | 1.718 | - | - | 0.735 | - | 0.983 | - | Mlig455_000690 {REF} {Length: 2225} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=184.0]; Ankyrin repeats (many copies) [PF13637.8, score=128.0]; Ankyrin repeat [PF00023.32, score=96.2]; Ankyrin repeats (many copies) [PF13857.8, score=94.5]; Ankyrin repeat [PF13606.8, score=92.4]; SOCS box [PF07525.18, score=29.0]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=120, Expect=6e-28]; ENSG00000135299, ANKRD6, ankyrin repeat domain 6, [Score=119, Expect=7e-28]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=122, Expect=1e-28]; ENSMUSG00000040183, Ankrd6, ankyrin repeat domain 6, [Score=122, Expect=6e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=121, Expect=1e-28]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=97.4, Expect=6e-21]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [RH, Score=549, Expect=0.0]} {RNA1509_43489} {RNA1310_16486.1} {RNA815_13229} |
17. | MligTC455_48258 | 34 | 0.71 | Mlig455_020899 | Neo: - Age: Down-Down-Up |
VAV3 | 1.71 | - | - | - | - | 0.975 | 0.735 | Mlig455_020899 {REF} {Length: 3371} {Pfam: Calponin homology (CH) domain [PF00307.33, score=42.1]; RhoGEF domain [PF00621.22, score=39.9]; SH2 domain [PF00017.26, score=27.7]; CAMSAP CH domain [PF11971.10, score=19.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=18.8]} {Human: ENSG00000134215, VAV3, vav guanine nucleotide exchange factor 3, [Score=142, Expect=3e-34]; ENSG00000160293, VAV2, vav guanine nucleotide exchange factor 2, [Score=141, Expect=5e-34]} {Mouse: ENSMUSG00000009621, Vav2, vav 2 oncogene, [Score=140, Expect=6e-34]; ENSMUSG00000033721, Vav3, vav 3 oncogene, [Score=139, Expect=1e-33]} {Celegans: WBGene00006887, vav-1, [Score=109, Expect=4e-24]} {Smed: dd_Smed_v6_6109_0_1, dd_Smed_v6_6109_0_1, [Score=96.7, Expect=2e-20]} {RNA1310_24185} {RNA815_29420} |
18. | MligTC455_47949 | 48 | 1 | Mlig455_026482, Mlig455_026492 | Neo: - Age: - |
CHRNA3 | 1.709 | - | - | 0.955 | - | 0.754 | - | Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} |
19. | MligTC455_39752 | 68 | 1.41 | Mlig455_003074 | Neo: - Age: - Region-enriched R2: 3.667/0.04790 |
SBK1 | 1.691 | - | - | 0.962 | - | 0.729 | - | Mlig455_003074 {REF} {Length: 1737} {Pfam: Protein kinase domain [PF00069.27, score=155.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=101.0]; Kinase-like [PF14531.8, score=22.6]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.3]} {Human: ENSG00000188322, SBK1, SH3 domain binding kinase 1, [RH, Score=262, Expect=9e-84]} {Mouse: ENSMUSG00000042978, Sbk1, SH3-binding kinase 1, [RH, Score=263, Expect=2e-84]} {Dmel: FBgn0031855, CG11221, [RH, Score=224, Expect=4e-69]} {Celegans: WBGene00015293, C01C4.3, Putative serine/threonine-protein kinase C01C4.3, [RH, Score=184, Expect=5e-55]} {Smed: dd_Smed_v6_12166_0_1, dd_Smed_v6_12166_0_1, [Score=109, Expect=5e-26]} {RNA1310_28583} {RNA815_17334} |
20. | MligTC455_47641 | 250 | 5.21 | Mlig455_007026, Mlig455_069139 | Neo: - Age: Down-Up-Up |
1.682 | - | - | 0.957 | 0.725 | - | - | Mlig455_007026 {REF} {Length: 2110} {RNA1509_55500} {RNA1310_26431} {RNA815_24412} Mlig455_069139 {REF} {Length: 2221} {RNA1509_55500} {RNA1310_26431, RNA1509_55500} {RNA1509_55500, RNA815_24412} |
|
21. | MligTC455_35769 | 90 | 1.87 | Mlig455_034140, Mlig455_050376, Mlig455_062180 | Neo: - |
1.68 | - | - | 0.727 | - | 0.953 | - | Mlig455_034140 {REF} {Length: 1714} {RNA1509_25690} {RNA1310_57234} {RNA815_17883} Mlig455_050376 {REF} {Length: 2093} {TRANSSPLICED} {RNA1509_54944} {RNA1310_23258} {RNA815_47172} Mlig455_062180 {REF} {Length: 90} {NoTransDecoderORF} {RNA1509_25690} {RNA1310_65891} {RNA815_17883} |
|
22. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 1.673 | - | - | 0.956 | - | 0.717 | - | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
23. | MligTC455_17377 | 32 | 0.67 | Mlig455_041286 | Neo: - Age: - |
1.66 | - | - | - | - | 0.957 | 0.703 | Mlig455_041286 {REF} {Length: 912} {NoTransDecoderORF} {RNA1310_106511} | |
24. | MligTC455_18522 | 455 | 9.47 | Mlig455_008847, Mlig455_008948 | Neo: - Age: logFC(26M/2M)=-0.379 |
RASEF | 0.987 | - | - | 0.987 | - | - | - | Mlig455_008847 {REF} {Length: 4934} {Pfam: Ras family [PF00071.24, score=159.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=100.2]; ADP-ribosylation factor family [PF00025.23, score=54.0]; EF-hand domain [PF13405.8, score=28.8]; EF-hand domain pair [PF13499.8, score=28.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.0]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=238, Expect=7e-67]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [RH, Score=259, Expect=4e-75]} {Dmel: FBgn0285937, Rab1, [Score=134, Expect=9e-36]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=177, Expect=1e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [RH, Score=189, Expect=7e-51]} {RNA1310_9926} {RNA815_2505} Mlig455_008948 {REF} {Length: 4701} {Pfam: Ras family [PF00071.24, score=159.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=100.2]; ADP-ribosylation factor family [PF00025.23, score=54.0]; EF-hand domain [PF13405.8, score=31.0]; EF-hand domain pair [PF13499.8, score=28.9]; 50S ribosome-binding GTPase [PF01926.25, score=25.9]; EF hand [PF00036.34, score=20.0]; EF hand [PF13202.8, score=19.4]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=184, Expect=2e-48]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [RH, Score=261, Expect=7e-76]} {Dmel: FBgn0285937, Rab1, [Score=134, Expect=1e-35]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=177, Expect=1e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [RH, Score=189, Expect=3e-51]} {RNA1310_9926} {RNA815_2505} |
25. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
0.986 | - | - | - | - | 0.986 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
26. | MligTC455_15720 | 37 | 0.78 | Mlig455_000177 | Neo: - Age: Up-Down-Down |
TRPC3 | 0.985 | - | - | 0.985 | - | - | - | Mlig455_000177 {REF} {Length: 4780} {Pfam: Transient receptor ion channel II [PF08344.13, score=91.7]; Ion transport protein [PF00520.33, score=56.1]; Ankyrin repeats (3 copies) [PF12796.9, score=34.0]; Ankyrin repeat [PF13606.8, score=29.0]; Ankyrin repeat [PF00023.32, score=24.2]} {Human: ENSG00000138741, TRPC3, transient receptor potential cation channel subfamily C member 3, [Score=517, Expect=2e-166]; ENSG00000137672, TRPC6, transient receptor potential cation channel subfamily C member 6, [Score=506, Expect=2e-162]; ENSG00000069018, TRPC7, transient receptor potential cation channel subfamily C member 7, [Score=506, Expect=4e-163]} {Mouse: ENSMUSG00000027716, Trpc3, transient receptor potential cation channel, subfamily C, member 3, [Score=511, Expect=2e-164]; ENSMUSG00000021541, Trpc7, transient receptor potential cation channel, subfamily C, member 7, [Score=507, Expect=2e-163]; ENSMUSG00000031997, Trpc6, transient receptor potential cation channel, subfamily C, member 6, [Score=501, Expect=1e-160]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=451, Expect=1e-139]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [Score=448, Expect=9e-140]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [RH, Score=1276, Expect=0.0]} {RNA1509_39636} {RNA1310_5314} {RNA815_4923} |
27. | MligTC455_52443 | 19 | 0.4 | Mlig455_058564 | Neo: - Age: - |
0.985 | - | - | 0.985 | - | - | - | Mlig455_058564 {REF} {Length: 2584} {RNA1310_86967} | |
28. | MligTC455_17412 | 44 | 0.91 | Mlig455_069737 | Neo: - Age: - Region-enriched R2: 5.062/0.00923 |
0.983 | - | - | 0.983 | - | - | - | Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912} | |
29. | MligTC455_45064 | 98 | 2.04 | Mlig455_059206 | Neo: - Age: - Region-enriched R2: 3.378/0.01843 |
MTUS2 | 0.983 | - | - | 0.983 | - | - | - | Mlig455_059206 {REF} {Length: 4973} {Human: ENSG00000132938, MTUS2, microtubule associated scaffold protein 2, [RH, Score=70.5, Expect=1e-11]} {Mouse: ENSMUSG00000029651, Mtus2, microtubule associated tumor suppressor candidate 2, [RH, Score=72.0, Expect=3e-12]} {Dmel: FBgn0015600, toc, toucan, [RH, Score=58.5, Expect=3e-08]} {RNA1509_44985, RNA1509_58911} {RNA1310_13922.1, RNA1509_44985} {RNA1509_44985, RNA815_11784} |
30. | MligTC455_47296 | 62 | 1.29 | Mlig455_052965 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_052965 {REF} {Length: 1293} {Pfam: TMEM206 protein family [PF15122.8, score=31.5]} {RNA1509_47607} {RNA1310_18723} {RNA815_19071} | |
31. | MligTC455_25176 | 7 | 0.14 | Mlig455_000293, Mlig455_067923 | Neo: - Age: Up-Down-Down |
DYRK2 | 0.982 | - | - | - | - | 0.982 | - | Mlig455_000293 {REF} {Length: 2536} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=191.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=85.1]; Phosphotransferase enzyme family [PF01636.25, score=21.9]; ABC1 atypical kinase-like domain [PF03109.18, score=21.0]; RIO1 family [PF01163.24, score=18.9]} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [RH, Score=620, Expect=0.0]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [RH, Score=625, Expect=0.0]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [RH, Score=543, Expect=0.0]} {Celegans: WBGene00003150, mbk-2, Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2, [RH, Score=561, Expect=0.0]} {Smed: dd_Smed_v6_10966_0_2, dd_Smed_v6_10966_0_2, [RH, Score=597, Expect=0.0]} {RNA1509_23467} {RNA1310_28330.1, RNA1509_23467} {RNA1509_23467, RNA815_20085} Mlig455_067923 {REF} {Length: 480} {TRANSSPLICED} {Human: ENSG00000127334, DYRK2, dual specificity tyrosine phosphorylation regulated kinase 2, [Score=64.7, Expect=2e-12]; ENSG00000143479, DYRK3, dual specificity tyrosine phosphorylation regulated kinase 3, [Score=62.8, Expect=5e-12]} {Mouse: ENSMUSG00000028630, Dyrk2, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2, [Score=71.2, Expect=9e-15]} {Dmel: FBgn0027101, Dyrk3, Dual-specificity tyrosine phosphorylation-regulated kinase 3, [Score=56.2, Expect=1e-09]} {Smed: dd_Smed_v6_10045_0_1, dd_Smed_v6_10045_0_1, [Score=67.4, Expect=7e-14]} {RNA1509_23467} {RNA1310_28330.2} {RNA815_20085} |
32. | MligTC455_45437 | 7306 | 152.21 | Mlig455_070342 | Neo: - Age: logFC(26M/2M)=0.265 Region-enriched R8: 2.560/0.00001 |
0.982 | - | - | - | - | - | 0.982 | Mlig455_070342 {REF} {Length: 1293} {RNA1509_3109, RNA1509_47880} {RNA1310_74049, RNA1509_3109, RNA1509_47880} {RNA1509_3109, RNA1509_47880, RNA815_20278.2} | |
33. | MligTC455_16221 | 370 | 7.7 | Mlig455_033881 | Neo: - Age: - Region-enriched R8: 3.263/0.00115 |
0.977 | - | - | - | - | - | 0.977 | Mlig455_033881 {REF} {Length: 1113} {RNA1310_29964} {RNA815_15923} | |
34. | MligTC455_48655 | 235 | 4.9 | Mlig455_016685, Mlig455_051240 | Neo: - Age: - |
ONECUT1 | 0.974 | - | - | 0.974 | - | - | - | Mlig455_016685 {REF} {Length: 3882} {Pfam: CUT domain [PF02376.17, score=113.6]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=214, Expect=1e-62]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=186, Expect=4e-52]; ENSMUSG00000045991, Onecut2, one cut domain, family member 2, [Score=185, Expect=7e-52]; ENSMUSG00000045518, Onecut3, one cut domain, family member 3, [Score=184, Expect=3e-51]} {Dmel: FBgn0028996, onecut, [Score=217, Expect=1e-60]} {Celegans: WBGene00015934, ceh-48, One cut domain family member, [Score=187, Expect=6e-53]} {Smed: dd_Smed_v6_16472_0_1, dd_Smed_v6_16472_0_1, [Score=214, Expect=2e-60]} {RNA1509_56542} {RNA1310_35187} {RNA815_16352} Mlig455_051240 {REF} {Length: 3794} {Pfam: CUT domain [PF02376.17, score=113.5]; Homeodomain [PF00046.31, score=43.2]; Homeobox KN domain [PF05920.13, score=22.7]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=276, Expect=8e-86]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=276, Expect=8e-86]} {Dmel: FBgn0028996, onecut, [Score=283, Expect=2e-83]} {Celegans: WBGene00000459, ceh-38, Homeobox protein ceh-38, [Score=201, Expect=1e-56]} {Smed: dd_Smed_v6_25197_0_2, dd_Smed_v6_25197_0_2, [Score=259, Expect=1e-76]} {RNA1509_56542} {RNA1310_35187, RNA1509_56542} {RNA1509_56542, RNA815_16352} |
35. | MligTC455_17475 | 56 | 1.16 | Mlig455_065300, Mlig455_065322 | Neo: - Age: - |
MYT1L | 0.972 | - | - | 0.972 | - | - | - | Mlig455_065300 {REF} {Length: 3149} {Pfam: Zinc finger, C2HC type [PF01530.20, score=77.6]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=130, Expect=2e-33]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=1e-29]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=6e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=7e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=125, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.4, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=123, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=132, Expect=7e-35]} {RNA1310_120779} Mlig455_065322 {REF} {Length: 1854} {Pfam: Zinc finger, C2HC type [PF01530.20, score=74.9]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=129, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=128, Expect=7e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=6e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=124, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.0, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=124, Expect=2e-30]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=133, Expect=3e-35]} {RNA1310_120779} |
36. | MligTC455_42020 | 58 | 1.22 | Mlig455_059333 | Neo: - Age: - |
WSCD2 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_059333 {REF} {Length: 1392} {Pfam: WSC domain [PF01822.21, score=60.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.5, Expect=1e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.5, Expect=9e-11]} {RNA1509_57286} {RNA1310_34378} {RNA815_35918} |
37. | MligTC455_09455 | 51 | 1.06 | Mlig455_029990 | Neo: - Age: - Region-enriched R2: 4.710/0.00601 |
0.971 | - | - | 0.971 | - | - | - | Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143} | |
38. | MligTC455_49878 | 31 | 0.65 | Mlig455_050656 | Neo: - Age: - |
CHRNA10 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952} |
39. | MligTC455_13282 | 95 | 1.99 | Mlig455_021294 | Neo: - Age: Down-Up-Down |
0.969 | - | - | 0.969 | - | - | - | Mlig455_021294 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_63724} {RNA815_38056} | |
40. | MligTC455_13897 | 26 | 0.54 | Mlig455_007882 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_007882 {REF} {Length: 1288} {RNA1310_105239.2} {RNA815_16034.1} | |
41. | MligTC455_21051 | 68 | 1.41 | Mlig455_000823 | Neo: - Age: - Region-enriched R2: 4.547/0.01054 |
KRAS | 0.969 | - | - | - | - | 0.969 | - | Mlig455_000823 {REF} {Length: 3832} {Pfam: Ras family [PF00071.24, score=191.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=74.6]; ADP-ribosylation factor family [PF00025.23, score=40.0]; RsgA GTPase [PF03193.18, score=27.2]; Elongation factor Tu GTP binding domain [PF00009.29, score=26.8]; 50S ribosome-binding GTPase [PF01926.25, score=26.3]} {Human: ENSG00000133703, KRAS, KRAS proto-oncogene, GTPase, [RH, Score=279, Expect=1e-96]; ENSG00000174775, HRAS, HRas proto-oncogene, GTPase, [RH, Score=276, Expect=1e-95]; ENSG00000276536, HRAS, HRas proto-oncogene, GTPase, [RH, Score=276, Expect=1e-95]; ENSG00000213281, NRAS, NRAS proto-oncogene, GTPase, [RH, Score=271, Expect=1e-93]} {Mouse: ENSMUSG00000030265, Kras, Kirsten rat sarcoma viral oncogene homolog, [RH, Score=283, Expect=2e-98]; ENSMUSG00000025499, Hras, Harvey rat sarcoma virus oncogene, [RH, Score=276, Expect=9e-96]; ENSMUSG00000027852, Nras, neuroblastoma ras oncogene, [RH, Score=273, Expect=3e-94]} {Dmel: FBgn0003205, Ras85D, Ras oncogene at 85D, [RH, Score=273, Expect=1e-94]} {Celegans: WBGene00002335, let-60, Ras protein let-60, [RH, Score=264, Expect=5e-91]} {Smed: dd_Smed_v6_2885_0_1, dd_Smed_v6_2885_0_1, [RH, Score=260, Expect=1e-89]} {RNA1509_38188} {RNA1310_33362} {RNA815_12962} |
42. | MligTC455_45436 | 10799 | 224.98 | Mlig455_057495 | Neo: - Age: Down-Down-Up Region-enriched R8: 2.400/0.00013 |
0.966 | - | - | - | - | - | 0.966 | Mlig455_057495 {REF} {Length: 870} {RNA1509_3109} {RNA1310_74049} {RNA815_20278.2} | |
43. | MligTC455_52262 | 145 | 3.02 | Mlig455_055398 | Neo: - Age: - |
DHX9 | 0.966 | - | - | 0.966 | - | - | - | Mlig455_055398 {REF} {Length: 4891} {Pfam: Double-stranded RNA binding motif [PF00035.28, score=73.1]; Helicase conserved C-terminal domain [PF00271.33, score=52.8]; Helicase associated domain (HA2) [PF04408.25, score=50.2]; Oligonucleotide/oligosaccharide-binding (OB)-fold [PF07717.18, score=39.1]; DEAD/DEAH box helicase [PF00270.31, score=30.5]} {Human: ENSG00000135829, DHX9, DExH-box helicase 9, [RH, Score=1137, Expect=0.0]} {Mouse: ENSMUSG00000042699, Dhx9, DEAH (Asp-Glu-Ala-His) box polypeptide 9, [RH, Score=1120, Expect=0.0]} {Dmel: FBgn0002774, mle, maleless, [RH, Score=1058, Expect=0.0]} {Celegans: WBGene00004355, rha-1, Probable ATP-dependent RNA helicase A, [RH, Score=868, Expect=0.0]} {Smed: dd_Smed_v6_4815_0_1, dd_Smed_v6_4815_0_1, [RH, Score=1115, Expect=0.0]} {RNA1509_8352} {RNA1310_2204.1} {RNA815_3757} |
44. | MligTC455_52902 | 41 | 0.84 | Mlig455_053281 | Neo: - Age: - |
TRPC6 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_053281 {REF} {Length: 3581} {Pfam: Ion transport protein [PF00520.33, score=32.2]} {Human: ENSG00000137672, TRPC6, transient receptor potential cation channel subfamily C member 6, [Score=124, Expect=2e-28]} {Mouse: ENSMUSG00000031997, Trpc6, transient receptor potential cation channel, subfamily C, member 6, [Score=115, Expect=4e-26]; ENSMUSG00000021541, Trpc7, transient receptor potential cation channel, subfamily C, member 7, [Score=112, Expect=4e-25]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=111, Expect=9e-25]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=66.6, Expect=5e-11]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [Score=85.9, Expect=4e-17]} {RNA1509_36039} {RNA1310_4382} {RNA815_15390} |
45. | MligTC455_14371 | 14 | 0.28 | Mlig455_048246 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_048246 {REF} {Length: 1448} {Pfam: Sulfotransferase domain [PF19798.1, score=52.9]} {RNA1310_42847} {RNA815_35707} | |
46. | MligTC455_35275 | 40 | 0.84 | Mlig455_039117 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_039117 {REF} {Length: 2535} {RNA1310_18660} {RNA815_15449} | |
47. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
48. | MligTC455_43925 | 14 | 0.28 | Mlig455_007983 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_007983 {REF} {Length: 2821} {RNA1310_91563} | |
49. | MligTC455_07101 | 46 | 0.96 | Mlig455_062761 | Neo: - Age: Down-Up-Down |
POU4F1 | 0.962 | - | - | 0.962 | - | - | - | Mlig455_062761 {REF} {Length: 2816} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=109.3]; Homeodomain [PF00046.31, score=67.1]; Helix-turn-helix domain [PF13560.8, score=22.0]} {Human: ENSG00000152192, POU4F1, POU class 4 homeobox 1, [RH, Score=271, Expect=7e-87]; ENSG00000151615, POU4F2, POU class 4 homeobox 2, [RH, Score=269, Expect=4e-86]; ENSG00000091010, POU4F3, POU class 4 homeobox 3, [RH, Score=267, Expect=2e-86]} {Mouse: ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [RH, Score=271, Expect=6e-87]; ENSMUSG00000031688, Pou4f2, POU domain, class 4, transcription factor 2, [RH, Score=268, Expect=3e-86]; ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [RH, Score=266, Expect=2e-86]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [RH, Score=265, Expect=3e-85]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [RH, Score=236, Expect=4e-75]} {Smed: dd_Smed_v6_15555_0_1, dd_Smed_v6_15555_0_1, [RH, Score=305, Expect=5e-101]} {RNA1509_57422} {RNA1310_8139.2} {RNA815_32659} |
50. | MligTC455_25880 | 81 | 1.7 | Mlig455_005910 | Neo: - Age: logFC(26M/2M)=-0.680 |
PRR9 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_005910 {REF} {Length: 2049} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=45.8, Expect=7e-06]} {RNA1509_54214} {RNA1310_38311.2} {RNA815_8809.1} |
51. | MligTC455_35499 | 52 | 1.08 | Mlig455_016299, Mlig455_038116 | Neo: - Age: - |
ZC4H2, ZNF362 | 0.962 | - | - | - | - | - | 0.962 | Mlig455_016299 {REF} {Length: 1855} {Pfam: Zinc finger-containing protein [PF10146.11, score=183.1]; Autophagy protein 16 (ATG16) [PF08614.13, score=25.4]} {Human: ENSG00000126970, ZC4H2, zinc finger C4H2-type containing, [RH, Score=96.3, Expect=2e-22]} {Mouse: ENSMUSG00000035062, Zc4h2, zinc finger, C4H2 domain containing, [RH, Score=96.3, Expect=1e-22]} {Dmel: FBgn0030806, CG13001, [RH, Score=75.9, Expect=6e-15]} {Celegans: WBGene00014153, vab-23, [RH, Score=79.7, Expect=9e-17]} {Smed: dd_Smed_v6_6954_0_1, dd_Smed_v6_6954_0_1, [RH, Score=71.2, Expect=1e-13]} {RNA1310_19213} {RNA815_45611} Mlig455_038116 {REF} {Length: 2149} {Pfam: Zinc-finger double domain [PF13465.8, score=72.9]; Anti-sigma-K factor rskA [PF10099.11, score=45.5]; Zinc finger, C2H2 type [PF00096.28, score=35.1]; C2H2-type zinc finger [PF13912.8, score=26.6]; C2H2-type zinc finger [PF13894.8, score=19.6]} {Human: ENSG00000160094, ZNF362, zinc finger protein 362, [Score=179, Expect=3e-50]; ENSG00000126746, ZNF384, zinc finger protein 384, [Score=175, Expect=1e-47]} {Mouse: ENSMUSG00000028799, Zfp362, zinc finger protein 362, [Score=179, Expect=2e-50]; ENSMUSG00000038346, Zfp384, zinc finger protein 384, [Score=175, Expect=9e-48]} {Dmel: FBgn0267337, rn, rotund, [RH, Score=188, Expect=7e-51]} {Celegans: WBGene00003015, lin-29, Transcription factor, [RH, Score=168, Expect=5e-46]} {Smed: dd_Smed_v6_18940_0_1, dd_Smed_v6_18940_0_1, [RH, Score=304, Expect=5e-95]} {RNA1509_19836} {RNA1310_91821} {RNA815_11624.2} |
52. | MligTC455_38031 | 24 | 0.5 | Mlig455_049070 | Neo: - Age: - |
0.962 | - | - | 0.962 | - | - | - | Mlig455_049070 {REF} {Length: 2566} {RNA1310_26848} {RNA815_42675} | |
53. | MligTC455_44051 | 392 | 8.18 | Mlig455_008770, Mlig455_008804 | Neo: - Age: - Regeneration-downregulated BL: -5.343 Regeneration-depleted BL: -5.343 |
IPMK | 0.962 | - | - | - | - | 0.962 | - | Mlig455_008770 {REF} {Length: 3071} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=104.2]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=8e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=106, Expect=4e-25]} {Dmel: FBgn0031267, Ipk2, [Score=111, Expect=1e-27]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=1e-13]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=3e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405} Mlig455_008804 {REF} {Length: 2051} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=103.9]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=4e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=107, Expect=1e-25]} {Dmel: FBgn0031267, Ipk2, [Score=113, Expect=2e-28]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=9e-14]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=2e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405} |
54. | MligTC455_15425 | 20 | 0.41 | Mlig455_005371 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_005371 {REF} {Length: 1504} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.5]} {RNA1509_54681} {RNA1310_18763} {RNA815_17502} | |
55. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
56. | MligTC455_39365 | 88 | 1.84 | Mlig455_017196 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_017196 {REF} {Length: 2469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.8]} {RNA1310_52319.1} {RNA815_17448} | |
57. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
58. | MligTC455_34952 | 124 | 2.59 | Mlig455_012890 | Neo: - Age: Up-Down-Down Region-enriched R7: 3.857/0.02491 |
ANGPTL7 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_012890 {REF} {Length: 1624} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=123.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=102, Expect=1e-24]; ENSG00000120332, TNN, tenascin N, [Score=101, Expect=3e-23]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=98.2, Expect=2e-22]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=100, Expect=4e-24]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.4, Expect=4e-22]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=97.1, Expect=2e-22]} {Dmel: FBgn0034160, CG5550, [Score=107, Expect=2e-27]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=108, Expect=2e-26]} {RNA1509_54507} {RNA1310_26965} {RNA815_12335} |
59. | MligTC455_42626 | 3871 | 80.64 | Mlig455_022010, Mlig455_022016, Mlig455_058844 | Neo: - Age: - Region-enriched R8: 5.333/0.00000 |
NGFR | 0.96 | - | - | - | - | - | 0.960 | Mlig455_022010 {REF} {Length: 2807} {Pfam: Death domain [PF00531.24, score=43.7]; TNFR/NGFR cysteine-rich region [PF00020.20, score=39.8]; Tumor necrosis factor receptor member 16 trans-membrane domain [PF18422.3, score=33.9]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=21.0]} {Human: ENSG00000064300, NGFR, nerve growth factor receptor, [RH, Score=87.4, Expect=7e-18]} {Mouse: ENSMUSG00000000120, Ngfr, nerve growth factor receptor (TNFR superfamily, member 16), [RH, Score=90.9, Expect=3e-19]} {RNA1509_51303} {RNA1310_14301} {RNA815_11451.1} Mlig455_022016 {REF} {Length: 2180} {Pfam: Death domain [PF00531.24, score=43.4]; TNFR/NGFR cysteine-rich region [PF00020.20, score=36.4]; Tumor necrosis factor receptor member 16 trans-membrane domain [PF18422.3, score=33.6]} {Human: ENSG00000064300, NGFR, nerve growth factor receptor, [Score=88.2, Expect=4e-18]} {Mouse: ENSMUSG00000000120, Ngfr, nerve growth factor receptor (TNFR superfamily, member 16), [Score=58.9, Expect=8e-09]} {RNA1509_53598} {RNA1310_15008} {RNA815_11451.1} Mlig455_058844 {REF} {Length: 2237} {Pfam: Death domain [PF00531.24, score=43.5]; TNFR/NGFR cysteine-rich region [PF00020.20, score=37.8]; Tumor necrosis factor receptor member 16 trans-membrane domain [PF18422.3, score=33.9]} {Human: ENSG00000064300, NGFR, nerve growth factor receptor, [RH, Score=96.3, Expect=7e-21]} {Mouse: ENSMUSG00000000120, Ngfr, nerve growth factor receptor (TNFR superfamily, member 16), [RH, Score=99.4, Expect=5e-22]} {RNA1509_26617} {RNA1310_14301} {RNA815_26191} |
60. | MligTC455_10306 | 37 | 0.76 | Mlig455_062778 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_062778 {REF} {Length: 1644} {RNA1509_48973} {RNA1310_22428.2} {RNA815_17155.1} | |
61. | MligTC455_23457 | 314 | 6.54 | Mlig455_029520 | Neo: - Age: Up-Down-Up Region-enriched R7: 5.927/0.00000 Regeneration-upregulated BL: 4.346 Regeneration-enriched BL: 4.346 |
FZD10 | 0.959 | - | - | - | - | - | 0.959 | Mlig455_029520 {REF} {Length: 3781} {TRANSSPLICED} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=272.7]; Fz domain [PF01392.24, score=63.7]} {Human: ENSG00000111432, FZD10, frizzled class receptor 10, [Score=275, Expect=7e-83]} {Mouse: ENSMUSG00000081683, Fzd10, frizzled class receptor 10, [Score=273, Expect=4e-82]; ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [Score=267, Expect=2e-80]; ENSMUSG00000049551, Fzd9, frizzled class receptor 9, [Score=264, Expect=7e-79]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=198, Expect=4e-54]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=210, Expect=3e-59]} {Smed: dd_Smed_v6_11650_0_1, dd_Smed_v6_11650_0_1, [Score=259, Expect=1e-76]} {RNA1310_57348} {RNA815_40236} |
62. | MligTC455_02318 | 69 | 1.45 | Mlig455_044964 | Neo: - Age: - Region-enriched R8: 6.174/0.00046 |
0.958 | - | - | - | - | - | 0.958 | Mlig455_044964 {REF} {Length: 1245} {Pfam: Ets-domain [PF00178.24, score=22.6]} {Smed: dd_Smed_v6_5087_0_2, dd_Smed_v6_5087_0_2, [Score=49.3, Expect=8e-07]} {RNA1310_46665} {RNA815_51481} | |
63. | MligTC455_18444 | 177 | 3.69 | Mlig455_000582, Mlig455_030377, Mlig455_033966 | Neo: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_000582 {REF} {Length: 2058} {Smed: dd_Smed_v6_6823_0_2, dd_Smed_v6_6823_0_2, [Score=198, Expect=4e-57]} {RNA1310_26881} Mlig455_030377 {REF} {Length: 1982} {Smed: dd_Smed_v6_6823_0_1, dd_Smed_v6_6823_0_1, [Score=161, Expect=1e-43]} {RNA1310_26881} Mlig455_033966 {REF} {Length: 1779} {Smed: dd_Smed_v6_6823_0_1, dd_Smed_v6_6823_0_1, [Score=184, Expect=2e-52]} {RNA1310_26881} |
|
64. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
65. | MligTC455_42326 | 1048 | 21.82 | Mlig455_056343 | Neo: - Age: - Region-enriched R7: 2.634/0.00000 |
EVX1 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_056343 {REF} {Length: 1485} {Pfam: Homeodomain [PF00046.31, score=74.8]} {Human: ENSG00000106038, EVX1, even-skipped homeobox 1, [RH, Score=131, Expect=1e-34]; ENSG00000174279, EVX2, even-skipped homeobox 2, [RH, Score=130, Expect=8e-34]} {Mouse: ENSMUSG00000005503, Evx1, even-skipped homeobox 1, [RH, Score=131, Expect=1e-34]; ENSMUSG00000001815, Evx2, even-skipped homeobox 2, [RH, Score=131, Expect=3e-34]} {Dmel: FBgn0000606, eve, even skipped, [RH, Score=137, Expect=4e-37]} {Celegans: WBGene00006873, vab-7, Homeobox protein vab-7, [RH, Score=110, Expect=3e-28]} {Smed: dd_Smed_v6_18147_0_1, dd_Smed_v6_18147_0_1, [RH, Score=117, Expect=2e-32]} {RNA1509_36832} {RNA1310_42544} {RNA815_33148} |
66. | MligTC455_18492 | 32 | 0.68 | Mlig455_026506 | Neo: - Age: - |
ADRA1B | 0.957 | - | - | - | - | 0.957 | - | Mlig455_026506 {REF} {Length: 1747} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=271.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]} {Human: ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=244, Expect=8e-74]} {Mouse: ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=242, Expect=3e-73]} {Dmel: FBgn0266137, Dop1R2, Dopamine 1-like receptor 2, [RH, Score=310, Expect=2e-96]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_22802_0_1, dd_Smed_v6_22802_0_1, [RH, Score=325, Expect=9e-107]} {RNA1310_108893} |
67. | MligTC455_18700 | 19 | 0.4 | Mlig455_003655 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_003655 {REF} {Length: 471} {NoTransDecoderORF} {RNA1310_85204} | |
68. | MligTC455_25416 | 74 | 1.53 | Mlig455_023019, Mlig455_023116 | Neo: - Age: - |
KCNK18 | 0.957 | - | - | 0.957 | - | - | - | Mlig455_023019 {REF} {Length: 2752} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=20.3]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=8e-25]} {Dmel: FBgn0033257, sand, sandman, [Score=147, Expect=1e-39]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=157, Expect=1e-43]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=323, Expect=4e-107]} {RNA1509_41017} {RNA1310_13859.1} {RNA815_18063} Mlig455_023116 {REF} {Length: 3009} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=19.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=2e-22]; ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=1e-24]} {Dmel: FBgn0033257, sand, sandman, [Score=149, Expect=3e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=159, Expect=4e-44]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=325, Expect=1e-107]} {RNA1509_41017} {RNA1310_13859.1, RNA1509_41017} {RNA1509_41017, RNA815_18063} |
69. | MligTC455_30374 | 175 | 3.65 | Mlig455_011748, Mlig455_070004 | Neo: - Age: Down-Up-Down |
0.957 | - | - | - | - | - | 0.957 | Mlig455_011748 {REF} {Length: 2428} {Pfam: CUB domain [PF00431.22, score=21.7]} {RNA1509_26683} {RNA1310_43894} {RNA815_47918} Mlig455_070004 {REF} {Length: 4760} {Pfam: DEK C terminal domain [PF08766.13, score=21.4]} {RNA1509_23859} {RNA1310_25192} {RNA815_24957.1} |
|
70. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
71. | MligTC455_53276 | 52 | 1.07 | Mlig455_032898 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_032898 {REF} {Length: 473} {NoTransDecoderORF} {RNA1310_127585} {RNA815_54104} | |
72. | MligTC455_19934 | 704 | 14.66 | Mlig455_001454 | Neo: - Age: - Region-enriched R8: 4.340/0.00000 |
HOXA10 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_001454 {REF} {Length: 2331} {Pfam: Homeodomain [PF00046.31, score=71.5]; Protein of unknown function (DUF2722) [PF10846.10, score=21.4]; Anti-sigma-K factor rskA [PF10099.11, score=20.2]} {Human: ENSG00000253293, HOXA10, homeobox A10, [RH, Score=97.4, Expect=1e-21]; ENSG00000128713, HOXD11, homeobox D11, [RH, Score=95.5, Expect=2e-21]; ENSG00000170178, HOXD12, homeobox D12, [RH, Score=95.1, Expect=9e-22]; ENSG00000123407, HOXC12, homeobox C12, [RH, Score=94.7, Expect=2e-21]; ENSG00000180818, HOXC10, homeobox C10, [RH, Score=94.4, Expect=6e-21]; ENSG00000005073, HOXA11, homeobox A11, [RH, Score=92.8, Expect=2e-20]; ENSG00000128710, HOXD10, homeobox D10, [RH, Score=92.8, Expect=2e-20]} {Mouse: ENSMUSG00000000938, Hoxa10, homeobox A10, [RH, Score=97.8, Expect=5e-22]; ENSMUSG00000042499, Hoxd11, homeobox D11, [RH, Score=95.9, Expect=1e-21]; ENSMUSG00000050328, Hoxc12, homeobox C12, [RH, Score=94.7, Expect=1e-21]; ENSMUSG00000022484, Hoxc10, homeobox C10, [RH, Score=94.4, Expect=5e-21]; ENSMUSG00000001823, Hoxd12, homeobox D12, [RH, Score=94.4, Expect=1e-21]; ENSMUSG00000050368, Hoxd10, homeobox D10, [RH, Score=93.2, Expect=1e-20]} {Dmel: FBgn0000015, Abd-B, Abdominal B, [RH, Score=106, Expect=7e-25]} {Celegans: WBGene00004024, php-3, Posterior Hox gene Paralog, [RH, Score=104, Expect=2e-25]} {Smed: dd_Smed_v6_9061_0_1, dd_Smed_v6_9061_0_1, [RH, Score=132, Expect=2e-34]} {RNA1509_50329} {RNA1310_36793} {RNA815_27715} |
73. | MligTC455_21693 | 48 | 1 | Mlig455_024307, Mlig455_024362, Mlig455_024476 | Neo: - Age: - |
AHR | 0.956 | - | - | 0.956 | - | - | - | Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588} Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588} Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588} |
74. | MligTC455_23046 | 38 | 0.8 | Mlig455_070735 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_070735 {REF} {Length: 573} {NoTransDecoderORF} {RNA1310_101740} | |
75. | MligTC455_26118 | 25 | 0.52 | Mlig455_036932 | Neo: - Age: logFC(26M/2M)=0.870 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_036932 {REF} {Length: 2939} {RNA1509_28486} {RNA1310_24343.1} {RNA815_8096} | |
76. | MligTC455_07669 | 60 | 1.26 | Mlig455_063001 | Neo: - Age: - |
LRG1 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_063001 {REF} {Length: 2041} {Pfam: Leucine rich repeat [PF13855.8, score=55.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=33.0]} {Human: ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=62.0, Expect=6e-10]; ENSG00000040608, RTN4R, reticulon 4 receptor, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000052316, Lrrc15, leucine rich repeat containing 15, [Score=52.8, Expect=5e-07]; ENSMUSG00000043496, Tril, TLR4 interactor with leucine-rich repeats, [Score=52.0, Expect=1e-06]} {Dmel: FBgn0262473, Tl, Toll, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=59.3, Expect=3e-09]} {RNA1310_98686} |
77. | MligTC455_42365 | 56 | 1.17 | Mlig455_037334 | Neo: - Age: - |
CHRNA3 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_037334 {REF} {Length: 3103} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=226.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=224.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=376, Expect=9e-124]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=372, Expect=2e-122]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=382, Expect=2e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=2e-123]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=451, Expect=2e-153]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=384, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=660, Expect=0.0]} {RNA1509_45903} {RNA1310_11151} {RNA815_10044.1} |
78. | MligTC455_13318 | 468 | 9.76 | Mlig455_037659 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_037659 {REF} {Length: 2609} {Smed: dd_Smed_v6_20776_0_1, dd_Smed_v6_20776_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1509_12918, RNA1509_42831} {RNA1310_7526.1, RNA1509_42831} {RNA1509_42831, RNA815_9598.1} | |
79. | MligTC455_20097 | 1223 | 25.49 | Mlig455_023539, Mlig455_023644 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.339 Region-enriched R8: 3.355/0.00001 Regeneration-upregulated BL: 2.571 Regeneration-enriched BL: 2.571 |
0.954 | - | - | - | - | - | 0.954 | Mlig455_023539 {REF} {Length: 2548} {TRANSSPLICED} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206} {RNA815_15099} Mlig455_023644 {REF} {Length: 2780} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206, RNA1509_20731} {RNA1509_20731, RNA815_15099} |
|
80. | MligTC455_39863 | 67 | 1.39 | Mlig455_042375, Mlig455_043601 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_042375 {REF} {Length: 5732} {Pfam: Fibronectin type III domain [PF00041.23, score=32.1]; AAA domain [PF13401.8, score=23.0]; Septin [PF00735.20, score=21.9]; 50S ribosome-binding GTPase [PF01926.25, score=21.5]; AIG1 family [PF04548.18, score=20.6]} {RNA1509_55714} {RNA1310_2789} {RNA815_9007} Mlig455_043601 {REF} {Length: 3947} {Pfam: WSC domain [PF01822.21, score=39.3]; Fibronectin type III domain [PF00041.23, score=29.7]; AAA domain [PF13401.8, score=22.5]; Septin [PF00735.20, score=21.8]; 50S ribosome-binding GTPase [PF01926.25, score=21.4]; AIG1 family [PF04548.18, score=20.2]} {RNA1509_55714} {RNA1310_2789} {RNA815_9007} |
|
81. | MligTC455_15589 | 7 | 0.14 | Mlig455_018037 | Neo: - Age: Down-Up-Down |
0.953 | - | - | - | - | 0.953 | - | Mlig455_018037 {REF} {Length: 3443} {TRANSSPLICED} {Smed: dd_Smed_v6_6099_0_1, dd_Smed_v6_6099_0_1, [Score=87.8, Expect=2e-19]} {RNA1509_9501} {RNA1310_8454} {RNA815_6408} | |
82. | MligTC455_33362 | 91 | 1.89 | Mlig455_044594 | Neo: - Age: logFC(26M/2M)=-0.300 |
0.953 | - | - | 0.953 | - | - | - | Mlig455_044594 {REF} {Length: 3890} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=46.0]; EF hand [PF00036.34, score=37.3]; EF-hand domain [PF13405.8, score=35.1]; EF hand [PF13202.8, score=25.9]} {RNA1509_5069} {RNA1310_3608.1} {RNA815_1684.1} | |
83. | MligTC455_38279 | 69 | 1.44 | Mlig455_045200 | Neo: - Age: - |
NOL4L | 0.953 | - | - | - | - | 0.953 | - | Mlig455_045200 {REF} {Length: 1997} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=150, Expect=9e-40]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=150, Expect=1e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=147, Expect=2e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1310_76365.1} {RNA815_48196} |
84. | MligTC455_49208 | 466 | 9.7 | Mlig455_039543, Mlig455_051350 | Neo: - Age: - Region-enriched R7: 3.047/0.01708 |
C17orf97, SELPLG | 0.953 | - | - | - | - | 0.953 | - | Mlig455_039543 {REF} {Length: 1622} {Human: ENSG00000110876, SELPLG, selectin P ligand, [Score=68.2, Expect=3e-13]} {Celegans: WBGene00017794, mltn-13, MLt-TeN (Mlt-10) related, [Score=62.8, Expect=9e-12]} {RNA1310_47880} {RNA815_50555} Mlig455_051350 {REF} {Length: 3453} {Human: ENSG00000283985, C17orf97, chromosome 17 open reading frame 97, [Score=59.7, Expect=5e-10]; ENSG00000187624, C17orf97, chromosome 17 open reading frame 97, [Score=59.7, Expect=5e-10]; ENSG00000110876, SELPLG, selectin P ligand, [Score=58.2, Expect=2e-09]} {Celegans: WBGene00017794, mltn-13, MLt-TeN (Mlt-10) related, [Score=53.5, Expect=3e-08]} {RNA1509_45595} {RNA1310_47880} {RNA815_50555} |
85. | MligTC455_32720 | 105 | 2.19 | Mlig455_036630, Mlig455_036706 | Neo: - Age: - |
RAC2 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_036630 {REF} {Length: 2660} {Pfam: Ras family [PF00071.24, score=174.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=79.3]; ADP-ribosylation factor family [PF00025.23, score=24.8]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=255, Expect=2e-85]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=254, Expect=6e-85]; ENSG00000169750, RAC3, Rac family small GTPase 3, [Score=248, Expect=2e-82]} {Mouse: ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=254, Expect=4e-85]; ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=253, Expect=6e-85]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=248, Expect=1e-82]} {Dmel: FBgn0010333, Rac1, [Score=251, Expect=4e-84]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=258, Expect=6e-87]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=241, Expect=2e-80]} {RNA1509_56536} {RNA1310_27814, RNA1509_56536} {RNA1509_56536, RNA815_15553} Mlig455_036706 {REF} {Length: 2754} {Pfam: Ras family [PF00071.24, score=174.6]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=79.5]; ADP-ribosylation factor family [PF00025.23, score=25.0]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=255, Expect=1e-85]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=253, Expect=5e-85]; ENSG00000169750, RAC3, Rac family small GTPase 3, [Score=247, Expect=2e-82]} {Mouse: ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=253, Expect=3e-85]; ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=253, Expect=5e-85]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=247, Expect=1e-82]} {Dmel: FBgn0010333, Rac1, [Score=251, Expect=3e-84]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=258, Expect=4e-87]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=241, Expect=1e-80]} {RNA1509_56536} {RNA1310_27814} {RNA815_15553} |
86. | MligTC455_45919 | 242 | 5.04 | Mlig455_040207 | Neo: - Age: - |
PLSCR1 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_040207 {REF} {Length: 2652} {Pfam: Scramblase [PF03803.17, score=245.9]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=241, Expect=1e-77]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=231, Expect=8e-74]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=227, Expect=2e-72]} {Dmel: FBgn0052056, scramb1, scramblase 1, [RH, Score=241, Expect=2e-76]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=191, Expect=3e-59]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=297, Expect=6e-100]} {RNA1509_25839} {RNA1310_11207.1} {RNA815_13677} |
87. | MligTC455_49654 | 318 | 6.63 | Mlig455_060646 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_060646 {REF} {Length: 1858} {TRANSSPLICED} {Pfam: CD20-like family [PF04103.17, score=21.1]} {RNA1509_55295} {RNA1310_18318, RNA1509_55295} {RNA1509_55295, RNA815_18731} | |
88. | MligTC455_52348 | 196 | 4.08 | Mlig455_050601 | Neo: - Age: logFC(26M/2M)=-0.400 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_050601 {REF} {Length: 3282} {Pfam: Spt20 family [PF12090.10, score=19.8]} {RNA1509_7271} {RNA1310_26412} {RNA815_23572} | |
89. | MligTC455_14712 | 29 | 0.61 | Mlig455_005163, Mlig455_021626 | Neo: - Age: - |
PTGER4 | 0.951 | - | - | 0.951 | - | - | - | Mlig455_005163 {REF} {Length: 2466} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.4]} {Human: ENSG00000171522, PTGER4, prostaglandin E receptor 4, [Score=52.4, Expect=1e-06]} {Mouse: ENSMUSG00000039942, Ptger4, prostaglandin E receptor 4 (subtype EP4), [Score=55.8, Expect=8e-08]} {RNA1310_74292} {RNA815_48878} Mlig455_021626 {REF} {Length: 2225} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=52.4]} {Human: ENSG00000171522, PTGER4, prostaglandin E receptor 4, [Score=51.2, Expect=3e-06]} {Mouse: ENSMUSG00000039942, Ptger4, prostaglandin E receptor 4 (subtype EP4), [Score=54.7, Expect=2e-07]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_22356_0_1, dd_Smed_v6_22356_0_1, [RH, Score=49.7, Expect=2e-06]} {RNA1310_83392} {RNA815_48878} |
90. | MligTC455_37563 | 45 | 0.94 | Mlig455_025592, Mlig455_057216, Mlig455_060662 | Neo: - Age: Up-Down-Up |
GALR2, OPN4, TRHR | 0.951 | - | - | - | - | 0.951 | - | Mlig455_025592 {REF} {Length: 4246} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=86.7]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.2]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=58.5, Expect=8e-09]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.8, Expect=1e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=9e-09]; ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=55.8, Expect=3e-08]} {Dmel: FBgn0038874, ETHR, [Score=86.7, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=93.6, Expect=1e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=164, Expect=2e-47]} {RNA1509_10419} {RNA1310_74041} {RNA815_44148} Mlig455_057216 {REF} {Length: 2773} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=87.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.5]} {Human: ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.0, Expect=2e-08]; ENSG00000182687, GALR2, galanin receptor 2, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=7e-09]} {Dmel: FBgn0038874, ETHR, [Score=86.3, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=92.0, Expect=2e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=162, Expect=7e-47]} {RNA1509_50426} {RNA1310_74041} {RNA815_44148} Mlig455_060662 {REF} {Length: 1185} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=76.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=67.1]} {Human: ENSG00000122375, OPN4, opsin 4, [Score=50.4, Expect=3e-06]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=48.9, Expect=7e-06]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [Score=73.9, Expect=4e-14]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=77.0, Expect=3e-15]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [Score=144, Expect=6e-40]} {RNA1310_74041} {RNA815_42171} |
91. | MligTC455_11822 | 10 | 0.22 | Mlig455_037067 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_037067 {REF} {Length: 680} {RNA1310_11581.1} {RNA815_17912} | |
92. | MligTC455_14220 | 7 | 0.16 | Mlig455_011703, Mlig455_049836 | Neo: - Age: - |
ADORA2A | 0.95 | - | - | 0.950 | - | - | - | Mlig455_011703 {REF} {Length: 1346} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=141.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=68.3]; Olfactory receptor [PF13853.8, score=19.6]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=157, Expect=2e-43]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=152, Expect=4e-42]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=153, Expect=4e-42]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=152, Expect=1e-42]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=95.9, Expect=8e-22]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=101, Expect=2e-23]} {RNA1310_66272} {RNA815_52356} Mlig455_049836 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=139.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.0]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=155, Expect=2e-42]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=150, Expect=2e-41]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=151, Expect=2e-41]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=149, Expect=2e-41]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=93.6, Expect=5e-21]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=100, Expect=6e-23]} {RNA1310_66272} {RNA815_52356} |
93. | MligTC455_18227 | 82 | 1.71 | Mlig455_014781 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_014781 {REF} {Length: 4541} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=26.2]; Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_35479} {RNA1310_2311.1} {RNA815_13099} | |
94. | MligTC455_20890 | 29 | 0.6 | Mlig455_001461 | Neo: - Age: Down-Down-Up |
0.95 | - | - | - | - | 0.950 | - | Mlig455_001461 {REF} {Length: 2259} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=39.9]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [Score=87.4, Expect=6e-19]} {RNA1310_44182} | |
95. | MligTC455_33794 | 948 | 19.75 | Mlig455_060591 | Neo: - Age: logFC(26M/2M)=-0.355 Region-enriched R8: 2.325/0.02122 |
CNFN | 0.95 | - | - | - | - | - | 0.950 | Mlig455_060591 {REF} {Length: 1665} {Pfam: PLAC8 family [PF04749.19, score=60.7]} {Human: ENSG00000105427, CNFN, cornifelin, [RH, Score=70.9, Expect=2e-16]} {Mouse: ENSMUSG00000063651, Cnfn, cornifelin, [RH, Score=70.9, Expect=2e-16]} {Smed: dd_Smed_v6_3182_0_1, dd_Smed_v6_3182_0_1, [RH, Score=85.1, Expect=3e-22]} {RNA1509_35358, RNA1509_9786} {RNA1310_42064, RNA1509_35358, RNA1509_9786} {RNA1509_35358, RNA1509_9786, RNA815_27081} |
96. | MligTC455_38903 | 37 | 0.76 | Mlig455_055963, Mlig455_056073 | Neo: - Age: - |
KCNK5 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_055963 {REF} {Length: 986} {Pfam: Ion channel [PF07885.18, score=106.1]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=133, Expect=4e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=127, Expect=9e-33]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=108, Expect=6e-26]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=8e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} Mlig455_056073 {REF} {Length: 1284} {Pfam: Ion channel [PF07885.18, score=106.2]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=132, Expect=6e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=126, Expect=1e-32]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=106, Expect=2e-25]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=9e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} {RNA1310_133484} |